This inventor holds 1 USPTO granted patent. Top assignee: Ningbo Eisen Life Technology Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Xiaohui Zhou in Scald Infection Treatment
Introduction
Xiaohui Zhou is an innovative inventor based in Ningbo, China. He has made significant contributions to the field of medical treatments, particularly in developing methods for addressing scald infections. His work is characterized by a focus on practical applications that can improve patient care.
Latest Patents
Xiaohui Zhou holds a patent for a method of preparing a product for treating scald infections. The patent details a process that involves creating a ferrous sulfate hydrogel, which is effective for deep second-degree and third-degree scalds. The preparation process includes dissolving ferrous sulfate and vitamin C in sterile ultrapure water, heating the solution, and adding sodium alginate powder to form a stable colloid. This innovative approach aims to enhance the treatment options available for patients suffering from severe scald injuries.
Career Highlights
Xiaohui Zhou is associated with Ningbo Eisen Life Technology Co., Ltd., where he applies his expertise in developing medical products. His work at the company reflects a commitment to advancing healthcare solutions through innovative research and development.
Collaborations
Xiaohui collaborates with talented individuals such as Liangbin Hu and Haizhen Mo, who contribute to the research and development efforts at Ningbo Eisen Life Technology Co., Ltd. Their teamwork fosters an environment of creativity and innovation, leading to impactful advancements in medical treatments.
Conclusion
Xiaohui Zhou's contributions to the field of scald infection treatment exemplify the importance of innovation in healthcare. His patented methods and collaborative efforts highlight the potential for advancements that can significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile